Literature DB >> 25005268

Photodynamic therapy downregulates the function of regulatory T cells in patients with esophageal squamous cell carcinoma.

Eleonora Reginato1, Jörg Lindenmann, Cord Langner, Nina Schweintzger, Isabella Bambach, Freyja Smolle-Jüttner, Peter Wolf.   

Abstract

Photodynamic therapy (PDT) by selective photosensitization of cancer cells and subsequent laser application results in local tumor necrosis. However, the effects of PDT on immune function, which may depend on the type of immune response, are controversial. We investigated the immunological changes induced by PDT and the effect of PDT on level and function of regulatory T cells (Treg) in patients with invasive esophageal squamous cell carcinoma (ESCC). We analyzed patient's blood samples before and after PDT. Blood CD4+CD25+CD127-FoxP3+ Treg levels were quantified by FACS, and Treg function was evaluated by coculture proliferation assays with T effector (Teff) cells. We found that PDT abrogated the suppressive capacity of peripheral Treg (Days 7 and 14, p = 0.016) but had no effect on Treg levels. The effect of PDT on Treg function at Day 7 was accompanied by slight but statistically significant increases in peripheral neutrophil granulocytes (p = 0.035) and monocytes (p = 0.013) and a statistically significant increase (approximately 18-fold) in serum IL-6 levels (p = 0.008). In conclusion, PDT abolished Treg function, possibly due to increased IL-6 levels in treated ESCC patients. This may be crucial for an improved therapeutic outcome.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25005268     DOI: 10.1039/c4pp00186a

Source DB:  PubMed          Journal:  Photochem Photobiol Sci        ISSN: 1474-905X            Impact factor:   3.982


  9 in total

1.  T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?

Authors:  Florian Anzengruber; Pinar Avci; Lucas Freitas de Freitas; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2015-06-11       Impact factor: 3.982

2.  Activated T cells exhibit increased uptake of silicon phthalocyanine Pc 4 and increased susceptibility to Pc 4-photodynamic therapy-mediated cell death.

Authors:  David C Soler; Jennifer Ohtola; Hideaki Sugiyama; Myriam E Rodriguez; Ling Han; Nancy L Oleinick; Minh Lam; Elma D Baron; Kevin D Cooper; Thomas S McCormick
Journal:  Photochem Photobiol Sci       Date:  2016-05-10       Impact factor: 3.982

Review 3.  Photodynamic Therapy and Immunity: An Update.

Authors:  Riddhi Falk-Mahapatra; Sandra O Gollnick
Journal:  Photochem Photobiol       Date:  2020-04-23       Impact factor: 3.421

Review 4.  Boosting Tumor-Specific Immunity Using PDT.

Authors:  Nicole Maeding; Thomas Verwanger; Barbara Krammer
Journal:  Cancers (Basel)       Date:  2016-10-06       Impact factor: 6.639

Review 5.  Preclinical and Clinical Evidence of Immune Responses Triggered in Oncologic Photodynamic Therapy: Clinical Recommendations.

Authors:  Irati Beltrán Hernández; Yingxin Yu; Ferry Ossendorp; Mladen Korbelik; Sabrina Oliveira
Journal:  J Clin Med       Date:  2020-01-24       Impact factor: 4.241

Review 6.  Photodynamic Therapy-Mediated Immune Responses in Three-Dimensional Tumor Models.

Authors:  Nkune Williams Nkune; Nokuphila Winifred Nompumelelo Simelane; Hanieh Montaseri; Heidi Abrahamse
Journal:  Int J Mol Sci       Date:  2021-11-23       Impact factor: 5.923

Review 7.  Photodynamic Theranostics of Central Lung Cancer: Capabilities of Early Diagnosis and Minimally Invasive Therapy (Review).

Authors:  G V Papayan; A L Akopov
Journal:  Sovrem Tekhnologii Med       Date:  2021-12-28

Review 8.  Targeting Antitumor Immune Response for Enhancing the Efficacy of Photodynamic Therapy of Cancer: Recent Advances and Future Perspectives.

Authors:  Yamin Yang; Yue Hu; Hongjun Wang
Journal:  Oxid Med Cell Longev       Date:  2016-09-08       Impact factor: 6.543

9.  Immune Responses after Vascular Photodynamic Therapy with Redaporfin.

Authors:  Ana Catarina S Lobo; Lígia C Gomes-da-Silva; Paulo Rodrigues-Santos; António Cabrita; Manuel Santos-Rosa; Luís G Arnaut
Journal:  J Clin Med       Date:  2019-12-31       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.